Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Scientific Reports|August 29, 2025
Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancerMarta D Switlyk, Einar Dale, Svetlana Tafjord, et al.
Anticancer Research|December 30, 2022
Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole ScoringMichelle Leech, Ralph T H Leijenaar, Tord Hompland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2024
MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapyKjersti Skipar, Tord Hompland, Kjersti V Lund, et al.
Acta Oncologica (Stockholm, Sweden)|March 19, 2025
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized studyKjersti Skipar, Tord Hompland, Kjersti V Lund, et al.
Cancers|March 10, 2022
Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast CancerTorgeir Mo, Siri Helene Bertelsen Brandal, Alvaro Köhn-Luque, et al.
Ebiomedicine|June 25, 2020
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneityChristina S Fjeldbo, Tord Hompland, Tiril Hillestad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2022
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancerKjersti Skipar, Tord Hompland, Kjersti Vassmo Lund, et al.
British Journal of Cancer|March 25, 2022
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patientsUnn Beate Salberg, Vilde Eide Skingen, Christina Sæten Fjeldbo, et al.
Cancer Research|June 28, 2018
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer PatientsTord Hompland, Knut Håkon Hole, Harald Bull Ragnum, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2024
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre studyJoseph Marsilla, Jessica Weiss, Xiang Y Ye, et al.
Pageof 4